These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19465360)

  • 1. Amiodarone attenuates the proarrhythmic effects of dobutamine in patients with advanced congestive heart failure.
    Tsagalou EP; Gounopoulos P; Terrovitis JV; Drakos SG; Katsaros FT; Kaldara EE; Alexopoulos GP; Anastasiou-Nana MI
    Hellenic J Cardiol; 2009; 50(3):193-8. PubMed ID: 19465360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term intermittent dobutamine infusion combined with oral amiodarone improves the survival of patients with severe congestive heart failure.
    Nanas JN; Kontoyannis DA; Alexopoulos GP; Anastasiou-Nana MI; Tsagalou EP; Stamatelopoulos SF; Moulopoulos SD
    Chest; 2001 Apr; 119(4):1173-8. PubMed ID: 11296186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
    Drakos SG; Kanakakis JV; Nanas S; Bonios M; Kaldara E; Katsaros F; Pantsios C; Nanas JN
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reverse left ventricular remodeling by intermittent dobutamine infusions and amiodarone in end-stage heart failure due to idiopathic dilated cardiomyopathy.
    Nanas JN; Tsagalou EP; Nanas SN; Terrovitis JV; Tsolakis EJ; Toumanidis S; Papazoglou PD; Alexopoulos GP; Kanakakis J; Anastasiou-Nana MI
    Int J Cardiol; 2006 Apr; 108(2):237-43. PubMed ID: 16183152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term intermittent dobutamine infusion, combined with oral amiodarone for end-stage heart failure: a randomized double-blind study.
    Nanas JN; Tsagalou EP; Kanakakis J; Nanas SN; Terrovitis JV; Moon T; Anastasiou-Nana MI
    Chest; 2004 Apr; 125(4):1198-204. PubMed ID: 15078725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long-term survival benefit conferred by intermittent dobutamine infusions and oral amiodarone is greater in patients with idiopathic dilated cardiomyopathy than with ischemic heart disease.
    Tsagalou EP; Anastasiou-Nana MI; Terrovitis JV; Nanas SN; Alexopoulos GP; Kanakakis J; Nanas JN
    Int J Cardiol; 2006 Apr; 108(2):244-50. PubMed ID: 16023232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dobutamine effects on spontaneous variability of ventricular arrhythmias in patients with severe chronic heart failure: the Italian Multicenter Study.
    Puddu PE; Papalia U; Schiariti M; Usta C;
    Ital Heart J; 2004 Sep; 5(9):693-701. PubMed ID: 15568599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial.
    Oliva F; Latini R; Politi A; Staszewsky L; Maggioni AP; Nicolis E; Mauri F
    Am Heart J; 1999 Aug; 138(2 Pt 1):247-53. PubMed ID: 10426835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Levosimendan and dobutamine have a similar profile for potential risk for cardiac arrhythmias during 24-hour infusion in patients with acute decompensated heart failure].
    Tek M; Cavuşoğlu Y; Demirüstü C; Birdane A; Ünalır A; Görenek B; Göktekin Ö; Ata N
    Turk Kardiyol Dern Ars; 2010 Jul; 38(5):334-40. PubMed ID: 21200103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study.
    Burger AJ; Horton DP; LeJemtel T; Ghali JK; Torre G; Dennish G; Koren M; Dinerman J; Silver M; Cheng ML; Elkayam U;
    Am Heart J; 2002 Dec; 144(6):1102-8. PubMed ID: 12486437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic infusion of dobutamine and nitroprusside in patients with end-stage heart failure awaiting heart transplantation: safety and clinical outcome.
    Capomolla S; Febo O; Opasich C; Guazzotti G; Caporotondi A; La Rovere MT; Gnemmi M; Mortara A; Vona M; Pinna GD; Maestri R; Cobelli F
    Eur J Heart Fail; 2001 Oct; 3(5):601-10. PubMed ID: 11595609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart rate is a marker of amiodarone mortality reduction in severe heart failure. The GESICA-GEMA Investigators. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina-Grupo de Estudios Multicéntricos en Argentina.
    Nul DR; Doval HC; Grancelli HO; Varini SD; Soifer S; Perrone SV; Prieto N; Scapin O
    J Am Coll Cardiol; 1997 May; 29(6):1199-205. PubMed ID: 9137213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous amiodarone bolus for treatment of atrial fibrillation in patients with advanced congestive heart failure or cardiogenic shock.
    Hofmann R; Steinwender C; Kammler J; Kypta A; Wimmer G; Leisch F
    Wien Klin Wochenschr; 2004 Nov; 116(21-22):744-9. PubMed ID: 15628645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurohumoral activation and ventricular arrhythmias in patients with decompensated congestive heart failure: role of endothelin.
    Aronson D; Burger AJ
    Pacing Clin Electrophysiol; 2003 Mar; 26(3):703-10. PubMed ID: 12698670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose amiodarone in severe chronic heart failure.
    Biswas A; Dey SK; Banerjee AK; Roy S; Biswas PK; Chowdhury GK; Khan AK; Mitra KK; Chatterjee SS; Maity AK
    Indian Heart J; 1996; 48(4):361-4. PubMed ID: 8908821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of partial arrhythmia suppression with amiodarone on heart rate variability of patients with congestive heart failure.
    Rohde LE; Polanczyk CA; Moraes RS; Ferlin E; Ribeiro JP
    Am Heart J; 1998 Jul; 136(1):31-6. PubMed ID: 9665215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral enoximone as a substitute for intravenous catecholamine support in end-stage congestive heart failure.
    Jondeau G; Dubourg O; Delorme G; Arnal JF; Chikli F; Kamoun L; Dumas C; Bourdarias JP
    Eur Heart J; 1994 Feb; 15(2):242-6. PubMed ID: 8005127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent dobutamine hydrochloride infusions in outpatients with chronic congestive heart failure.
    Roffman DS; Applefeld MM; Grove WR; Talesnick BS; Sutton FJ; Newman KA; Reed WP
    Clin Pharm; 1985; 4(2):195-9. PubMed ID: 3987220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ivabradine treatment prevents dobutamine-induced increase in heart rate in patients with acute decompensated heart failure.
    Cavusoglu Y; Mert U; Nadir A; Mutlu F; Morrad B; Ulus T
    J Cardiovasc Med (Hagerstown); 2015 Sep; 16(9):603-9. PubMed ID: 24922198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.